Yamada H et al. |
Simvastatin-tacrolimus and simvastatin-cyclosporin interactions in rats. |
1998 |
Biopharm Drug Dispos |
pmid:9673778
|
Trindade E et al. |
Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation. |
1998 |
J. Hepatol. |
pmid:9672183
|
Polak J et al. |
Primary pulmonary hypertension: pathologist as patient. |
1998 May-Jun |
J R Coll Physicians Lond |
pmid:9670148
|
Gross A et al. |
Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. |
1998 |
EMBO J. |
pmid:9670005
|
Takamatsu Y et al. |
IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis. |
1998 |
Dermatology (Basel) |
pmid:9669111
|
Horigome A et al. |
Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells. |
1998 |
Immunopharmacology |
pmid:9667420
|
Romero E et al. |
[Tacrolimus and hypertrophic cardiomyopathy]. |
1998 |
Med Clin (Barc) |
pmid:9666425
|
Morris-Stiff G et al. |
Prospective randomised study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transpl. Int. |
pmid:9665010
|
Peter C et al. |
Does tacrolimus cause more severe anemia than cyclosporine A in children after renal transplantation? |
1998 |
Transpl. Int. |
pmid:9665008
|
Zhang JG et al. |
Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation. |
1998 |
Transpl. Int. |
pmid:9665007
|
Charco R et al. |
Early use of tacrolimus as rescue therapy for refractory liver allograft rejection. |
1998 |
Transpl. Int. |
pmid:9665004
|
Horimoto H et al. |
Transplantation tolerance by a combined therapy with sulfatide, anti-LFA-1/ICAM-1 monoclonal antibodies and FK506 in rat cardiac transplantation. |
1998 |
Transpl. Int. |
pmid:9665003
|
Jara P et al. |
Tacrolimus for steroid-resistant liver rejection in children. |
1998 |
Transpl. Int. |
pmid:9664996
|
Reggiani P et al. |
Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children. |
1998 |
Transpl. Int. |
pmid:9664995
|
Pou L et al. |
Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients. |
1998 |
Transpl. Int. |
pmid:9664994
|
Margarit C et al. |
Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation. |
1998 |
Transpl. Int. |
pmid:9664992
|
Hernández-Herrera G et al. |
Tacrolimus rescue therapy for cyclosporine-induced nephrotoxicity. |
1998 |
Transpl. Int. |
pmid:9664956
|
Kyo M et al. |
Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine. |
1998 |
Transpl. Int. |
pmid:9664955
|
Morris-Stiff G et al. |
Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome. |
1998 |
Transpl. Int. |
pmid:9664954
|
Morris-Stiff G et al. |
Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. |
1998 |
Transpl. Int. |
pmid:9664949
|
Hauser IA and Neumayer HN |
Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation. European Multicentre Tacrolimus (FK506) Renal Study Group. |
1998 |
Transpl. Int. |
pmid:9664948
|
Kokado Y et al. |
Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation. |
1998 |
Transpl. Int. |
pmid:9664945
|
Stockwell BR and Schreiber SL |
TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins. |
1998 |
Chem. Biol. |
pmid:9662508
|
Nagayasu T et al. |
Expression of proliferating cell nuclear antigen in bronchial epithelium after lung transplantation in the rat. |
1998 |
J. Heart Lung Transplant. |
pmid:9662091
|
Lai MM et al. |
Cain, a novel physiologic protein inhibitor of calcineurin. |
1998 |
J. Biol. Chem. |
pmid:9660798
|
Tsujikawa A et al. |
Tacrolimus (FK506) attenuates leukocyte accumulation after transient retinal ischemia. |
1998 |
Stroke |
pmid:9660400
|
Bader G et al. |
Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient. |
1998 |
J. Periodontol. |
pmid:9660343
|
McBride WJ et al. |
Allogeneic fetal intestinal transplantation with FK506 immunosuppression. |
1998 |
J. Pediatr. Surg. |
pmid:9660232
|
Fujino T et al. |
The immunosuppressive compound FK506 does not affect expulsion of Echinostoma trivolvis in C3H mice. |
1998 |
Parasitol. Res. |
pmid:9660146
|
Le Bihan S et al. |
Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. |
1998 |
Mol. Endocrinol. |
pmid:9658403
|
Sasa H et al. |
Hepatic extraction of tacrolimus in rats with experimental liver diseases. |
1998 |
Biol. Pharm. Bull. |
pmid:9657047
|
Nishioka T et al. |
[Is tacrolimus effective for ongoing renal allograft rejection?]. |
1998 |
Hinyokika Kiyo |
pmid:9656112
|
Morozumi K et al. |
[Current topics of the rejection pathology in human renal allografts]. |
1998 |
Hinyokika Kiyo |
pmid:9656109
|
Tamura K |
[Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin]. |
1998 |
Tanpakushitsu Kakusan Koso |
pmid:9655970
|
Matsui H et al. |
[Physiological role of calcineurin in central nervous system]. |
1998 |
Tanpakushitsu Kakusan Koso |
pmid:9655961
|
Cetinkale O et al. |
Involvement of neutrophils in ischemia-reperfusion injury of inguinal island skin flaps in rats. |
1998 |
Plast. Reconstr. Surg. |
pmid:9655420
|
Kommers T et al. |
Regulation of the phosphorylation of glial fibrillary acidic protein (GFAP) by glutamate and calcium ions in slices of immature rat spinal cord: comparison with immature hippocampus. |
1998 |
Neurosci. Lett. |
pmid:9654363
|
Tarumi K et al. |
The plasma FK506-binding protein 12 level is related to acute cellular rejection in small bowel transplantation. |
1998 |
Immunopharmacol Immunotoxicol |
pmid:9653668
|
Friberg H et al. |
Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. |
1998 |
J. Neurosci. |
pmid:9651198
|
Canzanello VJ et al. |
Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). |
1998 |
Liver Transpl Surg |
pmid:9649648
|
Gabe SM et al. |
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. |
1998 |
Gastroenterology |
pmid:9649460
|
Gruessner RW et al. |
Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. |
1998 |
Clin Transplant |
pmid:9642520
|
Kuwata T et al. |
A role of calcineurin in coreceptor regulation during differentiation of Cd4+Cd8+ T cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9642110
|
Murray M et al. |
Comparison of tacrolimus absorption in transplant patients receiving continuous versus interrupted enteral nutritional feeding. |
1998 |
Ann Pharmacother |
pmid:9640479
|
Morris-Stiff G and Jurewicz WA |
Single centre experience with mycophenolate mofetil for refractory rejection in cadaveric renal transplantation. |
1998 |
Transpl. Int. |
pmid:9638849
|
Takahara S et al. |
A comparative study of FK506 granules and capsules in renal transplant recipients. |
1998 |
Transpl. Int. |
pmid:9638846
|
Abraham RT |
Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. |
1998 |
Curr. Opin. Immunol. |
pmid:9638370
|
Baldari CT et al. |
NF-AT-luciferase reporter T cell lines as tools to screen immunosuppressive drugs. |
1998 |
Biologicals |
pmid:9637743
|
Resch K and Szamel M |
Molecular mechanisms of the immunosuppressive action of cyclosporin A. |
1997 Sep-Oct |
Int. J. Immunopharmacol. |
pmid:9637358
|
Schneeberger H et al. |
Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. |
1998 |
Transplant. Proc. |
pmid:9636642
|
Gerber DA et al. |
Immunosuppressive agents: recent developments in molecular action and clinical application. |
1998 |
Transplant. Proc. |
pmid:9636637
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Gruessner RW |
Antibody induction therapy in pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636632
|
Burke GW et al. |
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. |
1998 |
Transplant. Proc. |
pmid:9636627
|
Peddi VR et al. |
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636626
|
Bruce DS et al. |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636625
|
Ciancio G et al. |
Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636624
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Wiebe K et al. |
FK506 rescue therapy in lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636613
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Platz KP et al. |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636596
|
Lang M et al. |
Impact of immunosuppression in liver transplantation across a positive crossmatch. |
1998 |
Transplant. Proc. |
pmid:9636595
|
Mueller AR et al. |
Does initial graft function influence the outcome after liver transplantation? |
1998 |
Transplant. Proc. |
pmid:9636594
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Bekersky I et al. |
Bioequivalence of a new strength tacrolimus capsule under development. |
1998 |
Transplant. Proc. |
pmid:9636591
|
Liu WT et al. |
In vitro generation of tacrolimus metabolites and their detection in whole blood. |
1998 |
Transplant. Proc. |
pmid:9636590
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Langrehr JM et al. |
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636583
|
Bilbao I et al. |
Experience with neoral cyclosporine through the oral route in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636580
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Platz KP et al. |
FK506 for primary and rescue therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636570
|
Millis JM et al. |
Successful use of tacrolimus for initial rejection episodes after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636569
|
Zervos XA et al. |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636568
|
Jain A et al. |
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9636567
|
Van Buren D et al. |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). |
1998 |
Transplant. Proc. |
pmid:9636566
|
Wiesner RH |
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. |
1998 |
Transplant. Proc. |
pmid:9636565
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Kumar MS et al. |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis. |
1998 |
Transplant. Proc. |
pmid:9636549
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Woodle ES et al. |
Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group. |
1998 |
Transplant. Proc. |
pmid:9636526
|